Timber Pharmaceuticals EBITDA margin
Quel est le EBITDA margin de Timber Pharmaceuticals?
Le EBITDA margin de Timber Pharmaceuticals, Inc. est -6,761.26%
Quelle est la définition de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin des entreprises dans Health Care secteur sur NYSE par rapport à Timber Pharmaceuticals
Que fait Timber Pharmaceuticals?
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.
Entreprises avec ebitda margin similaire à Timber Pharmaceuticals
- MRG Metals Ltd a EBITDA margin de -6,925.40%
- AgeX Therapeutics Inc a EBITDA margin de -6,921.83%
- Ideal Power Inc a EBITDA margin de -6,891.05%
- Touchpoint a EBITDA margin de -6,858.82%
- Touchpoint a EBITDA margin de -6,858.82%
- ResApp Health a EBITDA margin de -6,830.03%
- Timber Pharmaceuticals a EBITDA margin de -6,761.26%
- Lumos Pharma Inc a EBITDA margin de -6,753.83%
- Energous Corp a EBITDA margin de -6,697.16%
- Orion Minerals a EBITDA margin de -6,644.02%
- Core Economy Investment a EBITDA margin de -6,643.26%
- Marquee Resources a EBITDA margin de -6,524.41%
- Locksley Resources Ltd a EBITDA margin de -6,503.93%